Blood-Based α-Synuclein Seeding-A New Era for Identifying Parkinsonian Syndromes
- PMID: 37489601
- DOI: 10.1002/mds.29555
Blood-Based α-Synuclein Seeding-A New Era for Identifying Parkinsonian Syndromes
Keywords: Parkinson's disease; multiple system atrophy; serum biomarker; synucleinopathies; α-synuclein seeding assay.
Comment on
-
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.Nat Med. 2023 Jun;29(6):1448-1455. doi: 10.1038/s41591-023-02358-9. Epub 2023 May 29. Nat Med. 2023. PMID: 37248302 Free PMC article.
References
-
- Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet 2021;397:2284-2303.
-
- Yoo D, Bang J-I, Ahn C, et al. Diagnostic value of α-synuclein seeding amplification assays in α-synucleinopathies: a systematic review and meta-analysis. Parkinsonism Relat Disord 2022;104:99-109.
-
- Siderowf A, Concha-Marambio L, Lafontant D-E, et al. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study. Lancet Neurol 2023;22:407-417.
-
- Kluge A, Bunk J, Schaeffer E, et al. Detection of neuron-derived pathological α-synuclein in blood. Brain 2022;145:3058-3071.
-
- Okuzumi A, Hatano T, Matsumoto G, et al. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies. Nat Med 2023;29:1448-1455.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
